ABSTRACT: This experiment was conducted to determine the significance of the peptide amino acid (PAA) contribution to amino acid (AA) net flux in the portal vein and to evaluate the capacity for peptide absorption in the different segments of the gastrointestinal tract of ruminants. Four sheep (64 ± 3 kg BW) were fitted with catheters and blood flow probes, allowing AA net flux measurements across the portal-(PDV) and mesenteric (MDV)-drained viscera and the rumen. Sheep were fed at maintenance a diet containing hay and extruded peas (70:30). Peptide absorption was investigated by a dose infusion of a mixture of peptides (casein hydrolysate, Pro-Phe, β-Ala-His, Gly-Gly) into the rumen. Control and postinjection net fluxes of plasma free amino acids (FAA) and PAA were determined. The concentration of plasma PAA was determined by quantification of amino acids before and after acid hydrolysis of samples first submitted to chemical deproteinization and ultrafiltration (3-kDa cut-off filter). During the control period a significant net release (12 mmol/h) of PAA was observed across the PDV, which
Introduction
The general concept that amino acids (AA) in ruminants are exclusively absorbed from the small intestine and only released in the bloodstream in the form of free AA (FAA) has been called into question (Webb et al., 1992; Matthews and Webb, 1995) . Measurement of the arterial-venous flux of AA across the portal-drained viscera (PDV) suggested that peptide AA (PAA) may contribute significantly to AA delivery to the liver (Webb et al., 1992) . However, controversy exists concerning the quantitative significance of this PAA flux. A consid-
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accounted for 35% of the sum of FAA and PAA net fluxes. This PDV flux of PAA mainly resulted from a MDV release of PAA (15 mmol/h). The net flux of total PAA across the ruminal wall was not significantly different from zero, but uptake of peptide Ile and release of peptide Gly were observed. The injection into the rumen of the peptide mixture increased the net release of peptide essential AA (EAA) across the MDV (P < .05) and the PDV (P < .10), and of peptide Pro and Phe across the non-MDV (P < .10). Peptide Ile uptake by the rumen tissues was decreased by the injection (P < .05). Significant increases in peptide Pro and Gly arterial concentrations were observed (P < .05). The β-AlaHis and Gly-Gly arterial concentrations and net fluxes across the PDV were not affected by their injections into the rumen. This study showed that PAA may contribute significantly to AA flux across the PDV of sheep, and that part of this flux can probably be attributed to peptide absorption from the gut lumen. When high concentrations of peptides are generated in the rumen the possibility of peptide absorption before the jejunum has to be considered. erable contribution (65 to 85%) of PAA to PDV net flux of AA (FAA + PAA) has been observed in steers (Webb et al., 1992; Koeln et al., 1993; Seal and Parker, 1996) . In sheep, large (90%; Webb et al., 1992) , low (20% for Phe; Neutze et al., 1996) , or nonsignificant (Backwell et al., 1997) contributions of PAA were reported. Furthermore, it seemed that PAA release in the portal vein of steers mainly originates from the non-mesenteric area (Webb et al., 1992; Seal and Parker, 1996) . The PAA released in the portal vein may originate either from gastrointestinal tract metabolism or from direct absorption of luminal peptides. In vitro (Matthews and Webb, 1995) and in vivo (Rémond et al., 2000) , permeability of the ruminant stomach epithelium to small peptides has been evidenced, but the contribution of absorption of luminal peptides to PDV net flux of PAA is still unknown. Not enough data are available in the literature to determine whether the discrepancies ob-served in PAA fluxes are attributable to animal species, physiological state, diet, or methodology involved in PAA determination.
The aim of the present work was to determine the significance of peptide net flux in the portal vein of sheep and the contribution of different areas of the gastrointestinal tract to this flux. Furthermore, a dose infusion of peptides into the rumen was performed to evaluate the significance of transmucosal passage of luminal peptides.
Materials and Methods

Animals and Diet
Four mature Texel wethers (64 ± 3 kg BW) were surgically prepared with a ruminal cannula (polyvinyl chloride, 40 mm o.d.), indwelling catheters, and blood flow probes. Surgical procedures and postsurgical care were conducted in accordance with national legislation on the care and use of laboratory animals. The catheters were implanted in the right ruminal vein, the mesenteric vein, the portal vein, and a mesenteric artery. Except for the mesenteric vein, the catheter material and surgical procedures for catheter implantation have been previously described (Rémond et al., 1993b; Ortigues et al., 1994) . The catheter in the mesenteric vein (polyvinyl chloride; 1.1 mm i.d., 1.9 mm o.d.) was directly inserted into the main arcade of the mesenteric vein. Approximately 10 cm was slid downstream into the vessel so that the tip of the catheter was 2 to 4 cm upstream from the junction of the cranial mesenteric vein (CMV) and the ileocecocolic vein. Transit-time ultrasonic blood flow probes (Transonic Systems, Ithaca, NY) were implanted around the right ruminal artery (3 mm, R-Series; Rémond et al., 1993b) , the portal vein (16 mm, A-Series; Rémond et al., 1998) , and the mesenteric vein. The blood flow probe (14 mm, A-Series) implanted around the CMV was positioned just upstream from the junction of the CMV and the ileocecocolic vein, 2 to 3 cm downstream from the tip of the mesenteric vein catheter. All catheters and blood flow probes remained patent throughout the experiment. Postmortem examinations of catheters showed correct placement of all catheters and probes.
The sheep were housed in individual pens (1 × 1.5 m) in a room under continuous lighting with controlled temperature (19 to 23°C). They were offered a diet containing 800 g of chopped orchardgrass hay and 350 g of extruded peas, providing 27.4 g of N/d and 10.6 MJ of ME/d. This diet was chosen because it generates a high level of soluble nonammonia N (NAN) in the rumen (Rémond et al., 1997) . Feed was delivered in 12 equal portions at 2-h intervals (from 0000) from an automatic feeder. The sheep were given ad libitum access to water and a salt block. Animals were adapted to the diet during 3 wk and to automatic feeding during 1 wk before sampling.
Experimental Procedures
The experiment started approximately 5 wk after surgery. On the day of sampling, each animal received, at 0945, an intraruminal injection (via the ruminal cannula) of a solution of Cr-EDTA (40 mL, 1.5 g of Cr/L) for the estimation of liquid phase outflow rate from the rumen. The injected solution was distributed in the different compartments of the rumen to promote quick mixing with ruminal digesta. At 1015, an intraruminal injection of a solution of AA was performed as for the Cr solution. The AA solution (pH 7) contained 40 g of peptone from casein (tryptic digest; Fluka, L'Isle d'Abeau Chesnes, France), 3 g of carnosine (β-Ala-His), 3 g of glycylglycine, and 3 g of prolylphenylalanine, diluted in 400 mL of water.
Blood samples (7 mL) were simultaneously withdrawn through the four catheters at 0845, 0915, 1045, 1115, 1215, 1315, 1415, and 1515 . They were collected into cold syringes containing anticoagulant (Monovett, Starstedt, Mosheim, France). Samples were rapidly placed on ice. Packed cell volume (PCV) was determined, and plasma was prepared from 4 mL of whole blood by centrifugation at 1,500 × g for 10 min at 4°C. The remaining whole blood was used for the determination of urea, ammonia, and hemoglobin concentrations (Rémond et al., 1993a) . Plasma (1 mL) was deproteinized with .1 mL of sulfosalicylic acid 40% (wt/vol) after addition of norleucine (.1 mL, 1.25 mM) used as an internal marker of AA concentration. Deproteinized samples were stored at −80°C.
Ruminal liquor was collected at 1100, 1130, 1230, 1430, 1630, and 2300 on the day of the injection and at 1100 the next day. Ruminal samples were filtered through nylon gauze and centrifuged (27,000 × g for 20 min at 4°C). A fraction of the supernate was deproteinized as described for plasma samples; the remaining supernate was kept frozen for Cr-EDTA determination.
Blood flow was measured continuously (from 0800 to 1600) with an ultrasonic transit time flowmeter (Transonic Systems) interfaced with a computer for data acquisition.
Laboratory Analyses
A preliminary experiment was conducted to determine the appropriate method for plasma preparation in view of PAA determination. Three methods were compared: simple chemical deproteinization with sulfosalicylic acid (Webb et al., 1992) , physical deproteinization by ultrafiltration (Seal and Parker, 1996) , and chemical deproteinization with an additional step of filtration (Galibois et al., 1991) . In this preliminary experiment, plasma samples were harvested from jugular blood of four sheep. They were subsampled into three fractions of 1 mL to which .1 mL of S-amino-ethylcysteine (SAEC) was added as an internal marker of amino acid concentration. One fraction (Ph-0) was diluted with an equal volume of sample dilution buffer Values are means of four sheep ± standard error; Ch-0 corresponds to simple chemical deproteinization, Ph-0 to physical deproteinization (10 kDa), and Ch-3 to chemical deproteinization + ultrafiltration (3 kDa). b EAA = essential amino acids; BCAA = branched-chain amino acids.
x,y,z Within a row, means lacking a common superscript letter differ (P < .05).
(Li-S; Beckman Instruments, Palo Alto, CA) and ultrafiltrated through a 10,000 M r cut-off filter (Centrisart1; Sartorius, Palaiseau, France) at 2,500 × g for 3 h at 4°C. The two others were deproteinized by addition of .1 mL of sulfosalicylic acid (SSA; 40%, wt/vol). Samples were mixed, allowed to stand 15 min at room temperature, and centrifuged (10,000 × g for 10 min at 4°C). One of the supernates was kept as it was (Ch-0), and the other (Ch-3) was diluted with an equal volume of Li-S buffer and filtered through a 3,000 M r cut-off filter (Centricon-3; Millipore, Bedford, MA) at 5,000 × g for 3 h at 4°C. Samples from each treatment (Ph-0, Ch-0, Ch-3) were divided into two portions. One of these (400 L) was hydrolyzed in 1 mL of 6 N HCl at 115°C for 24 h and evaporated to dryness with a centrifuge evaporator (RC10.10.; Jouan SA, Saint Herblain, France). The residue was resuspended in 1 mL of sample dilution buffer. Amino acid analysis was performed on each sample (before and after acid hydrolysis) by ion exchange chromatography on a physiological column of a 6300 Beckman Autoanalyzer (Beckman Instruments). In this particular instance, with those samples, accurate determination of SAEC in hydrolyzed samples was prevented by a component appearing during hydrolysis. So, for these samples AA concentrations were first corrected for dilution during the hydrolysis step (assuming an AA recovery of 100%) and then corrected using the internal standard of deproteinization of the nonhydrolyzed sample. The difference in AA concentration before and after hydrolysis was attributed to peptides. Cysteine and methionine, which are severely affected by acid hydrolysis, were not taken into account. Furthermore, during the hydrolysis, some of the Asn and Gln that disappears is converted to Asp and Glu, respectively. The peptide Asp and Glu concentrations presented are therefore overestimates, and they are reported as AsX and GlX, respectively.
According to the results obtained in the preliminary study (Table 1) , PAA concentrations in plasma and ruminal samples from the main experiment were determined after chemical deproteinization and ultrafiltration (Ch-3 treatment) as described above. Because of the difficulties encountered in SAEC determination during the preliminary study, norleucine was used as internal standard, and both free AA and total AA concentrations have been corrected using this standard. An unidentified molecule coelutes with Thr during analysis, and correct determination of Thr in hydrolyzed samples was not possible. Consequently, the concentration of this amino acid in peptide form was not reported.
Ruminal concentration of Cr-EDTA was determined by atomic absorption spectrometry.
Calculations and Statistics
Pool size and turnover rate of ruminal liquid were calculated from the decrease against time (t) in Cr concentration within the ruminal liquid phase. Ruminal outflow (mmol) of amino acids per time interval around samplings was calculated as ruminal concentration of AA (mM) × liquid outflow rate (L/h) × time interval (h). Time interval was defined as [(t − t −1 )/2 + (t +1 − t)/2], except for the first sampling time, for which the time interval used was [(t − t inj ) + (t +1 − t)/2], where t inj was time of injection. An approximate ruminal export of AA between 1015 and 1400 was then calculated by summing the outflow for each time interval.
Ruminal blood flow was estimated to be twice the blood flow in the right ruminal artery (Rémond et al, 1993b) . Plasma flow (PF) was calculated using the following equation: PF = BF × (1 − PCV), where BF represents blood flow, and PCV is for blood flowing within the probe. Ammonia and urea net fluxes were calculated for whole blood, whereas FAA and PAA net fluxes were calculated for plasma. Net fluxes of metabolite (M) were calculated, for each sampling time, with the following represents the ratio between the arterial and the venous blood concentrations of hemoglobin, and F represents blood or plasma flow. Hemoglobin concentration ratio was used to correct fluxes for water movement across vessels. A positive net flux indicates release of a nutrient, whereas a negative net flux implies uptake. Neutze et al. (1994) showed that, with a preparation similar to that used in this experiment, the CMV drained approximately 84% of the whole small intestine, and that approximately 10% of the CMV drainage originated from the colon (accounting for 20% of colon drainage). With such a preparation, MDV flux did not take into account the duodenum and the distal ileum. Nonmesentericdrained viscera flux of AA was calculated as the difference between PDV and MDV fluxes.
Average concentrations of arterial urea, ammonia, FAA, and PAA before injection were generated from the two sampling times before injection of the AA solution into the rumen. The effect of the injection on the arterial concentrations was tested using the repeated measures ANOVA of the GLM procedure of SAS (1988); the contrast transformation procedure was used to test differences between preinjection and subsequent concentrations.
Mean retention time of the liquid phase in the digestive compartments located between the rumen and the large intestine of sheep ranged from 4 to 5 h (Barry et al., 1985) . Thus, a return to preinjection fluxes of AA was expected during the last studied feeding cycle. Net fluxes were integrated on the first (0800 to 1000) and the last (1400 to 1600) feeding cycle of the sampling period and compared using a Student paired t-test. Whatever the blood compartment, no significant differences were observed in FAA and PAA net fluxes between these two periods. Thus, control net fluxes of AA were generated integrating data from the first and the last feeding cycle; postinjection net fluxes were generated integrating data from the two feeding cycles following the injection (1015 to 1400). A student paired t-test was used to compare FAA and PAA net fluxes with zero and to compare control and postinjection net fluxes; a probability of P < .10 was taken for significance. Because urea and ammonia net fluxes were significantly different between the first and the last feeding cycle, control fluxes for these two metabolites refer to average preinjection fluxes. The effect of AA injection on these traits was tested as for arterial concentrations.
Results
Effect of Plasma Sample Preparation on PAA Concentration
Data from the preliminary study on jugular plasma are given in Table 1 . Free AA concentration was 2,414 ± 48 M. The sample preparation significantly affected total PAA concentration. The AA attributed to PAA accounted for 63.5, 57.7, and 44.9% of FAA + PAA for sample preparation Ch-0, Ph-0, and Ch-3 respectively. If we assume that 10,000 Da is the limit between proteins and peptides, it can be estimated that simple chemical deproteinization (without additional filtration) overestimated plasma PAA concentration by approximately 28%. A comparison between Ph-0 and Ch-3 preparation suggests that small peptides accounted for 60% of plasma PAA.
Ruminal Traits
The AA composition of the solution injected in the rumen is shown in Figure 1 . The solution contained 323 mmol of AA, 19% as FAA. The variations with time in ruminal concentrations of FAA and low-molecularweight peptides (< 3 kDa) following the injection of the AA solution are given in Tables 2 and 3 . The concentrations observed on the day following the injection (at 1100) have been presented as control values. High concentrations (> 25 mM) of PAA were observed within the 75 min following the injection. Four hours after the injection, ruminal concentration of PAA was low (< 5 mM) but significantly higher than the control (1 mM). The volume of the ruminal liquid phase was on average 5.17 ± .11 L; liquid outflow rate from the rumen was .55 ± .01 L/h. The ruminal outflow of FAA during the postinjection period (1015 to 1400) was estimated to be 23 ± 3 mmol (14 mmol of essential FAA). The same estimation for PAA was 44 ± 4 mmol (22 mmol of essential PAA). Assuming a basal ruminal outflow of AA of .5 mmol/h, 64 mmol of injected AA (20%) escaped ruminal degradation as FAA and small peptides and flowed from the rumen during the postinjection period. Although the amount of carnosine injected in the rumen was lower than for Gly-Gly (13 vs 23 mM), its outflow from the rumen (2.26 ± .1 mmol) was higher than for GlyGly (.61 ± .3 mmol).
Blood Flow Rates
Blood flow rates throughout the sampling period averaged 2,334 ± 24, 470 ± 8, and 520 ± 12 mL/min for PDV, MDV, and rumen, respectively. Whatever the compartment, blood flow was not significantly affected by injection of the AA solution. On average, MDV and ruminal blood flow accounted for 20 and 22% of portal blood flow (PBF), respectively. The PCV was not affected by the time of sampling; average values for the artery and the portal and the mesenteric veins were 25.4 ± .5, 24.7 ± .5, and 25.1 ± .5%, respectively. Mean rates of plasma flow were 1,758 ± 23, 352 ± 7, and 388 ± 9 mL/min for PDV, MDV, and rumen, respectively.
Values for the ratio [Hb] a /[Hb] v did not show significant variation with time and were on average 1.012 ± .002, 1.014 ± .002, and 1.013 ± .001 for the rumen, MDV, and PDV, respectively.
Arterial Concentrations and Net Flux
Urea and Ammonia. Arterial concentration of NH 3 was approximately .10 mM and was not affected by the injection. Arterial concentration of urea linearly Table 2 . Free amino acid, carnosine, and Gly-Gly concentrations (mM) in the rumen of sheep (n = 4) after intraruminal injection of a solution containing casein hydrolysate, β-Ala-His, Gly-Gly, and Pro-Phe increased (P < .05) from 5.19 mM before the injection to 6.75 mM at the last sampling time. Before injection, the net flux of NH 3 across the rumen, MDV, and PDV was on average 12.0, 11.6, and 41.5 mmol/h, respectively. Ruminal and portal net releases of NH 3 increased after injection of the AA solution into the rumen (P < .05), whereas mesenteric net release was not affected. Before injection, net flux of urea across the rumen, MDV, and PDV was on average −6.7, −1.8, and −11.5 mmol/h, respectively. Ruminal net uptake of urea decreased after the injection, whereas PDV and MDV net uptakes were not affected.
Plasma Free Amino Acids. Arterial concentrations of FAA are given in Table 4 . The intraruminal injection of the AA solution significantly affected the arterial concentrations of free Ser, Gly, Ala, Cys, Leu, Phe, His, and Pro, and of peptide Gly and Pro. Arterial concentrations of these FAA with respect to time after injection are given in Figure 2 . Free Gly, Ala, Ser, and Cys concentrations decreased within the sampling period, whereas free Leu, Phe, His, and Pro and peptide Gly and Pro concentrations were significantly increased by the injection. Control and postinjection net fluxes of FAA across the PDV, MDV, non-MDV, and the rumen are given in Tables 5, 6 , 7, and 8, respectively. During the control period, net flux of FAA across the MDV was 141% of net flux of FAA across PDV. Rumen tissue net uptake accounted for approximately 20% of the non-MDV uptake of FAA. Considering individual AA net fluxes, converse to the release of the other AA, net uptake of Gln across the PDV was observed. This was fully attributable to non-MDV net uptake, suggesting that in the MDV arterial Gln uptake balanced Gln uptake from the gut lumen. Conversely, Ala and Asp net releases were totally attributable to MDV release. Except for Orn, the non-MDV tissues released none of the AA during the control period. The intraruminal injection of the AA solution led to an increase in PDV net release of FAA [both total AA and essential AA [EAA] ). From the increase in PDV net flux of FAA, it can be calculated that, during the postinjection period (1015 to 1400), 21 mmol of total AA (10 mmol of EAA) was released in the portal vein in response to the injection. The increase in FAA net release in the PDV originated both from an increase in MDV net release and from a decrease in non-MDV net uptake. Considering individual FAA only, Thr, Ser, Val, Met, Ile, Leu, Phe, Lys, and Pro PDV net fluxes were significantly increased. Significant increases in MDV net fluxes of Met, Ile, Leu, and Pro were observed. Net uptakes of Thr, Ser, Gly, Val, Lys, and Pro by the non-MDV were significantly reduced by the injection, and a Phe net release appeared. Except Cys, for which a very small but significant decrease in net uptake was observed, none of the FAA net fluxes across the rumen wall were affected by the injection.
Figure 2.
Arterial concentrations (mM) of amino acids in arterial plasma in response to intraruminal injection of a mixture of casein hydrolysate, β-Ala-His, Gly-Gly, and Pro-Phe: (a) free amino acids, (b) free and peptide glycine, and (c) free and peptide proline. The concentrations that are different from preinjection ones are indicated by †P < .10, *P < .05, and **P < .01. Values are means ± SE (n = 4). b EAA = essential amino acids; AsX is Asp for FAA and Asp + Asn for PAA; GlX is Glu for FAA and Glu + Gln for PAA. c P is the probability for postinjection flux to be different from control flux; NS = nonsignificant; **P < .01, *P < .05, †P < .10. Table 4 . During the control period plasma PAA concentration accounted for 32% of the sum of FAA and PAA. The injection of the AA solution significantly increased the peptide Gly and Pro concentrations in arterial plasma. Arterial concentration of these PAA with respect to time after injection is given in Figure 2 . The dipeptide Gly-Gly was not detectable in arterial and venous plasma samples before or after the injection of the AA solution into the rumen, and carnosine concentration was too low to be determined precisely. Control and postinjection net fluxes of FAA across the PDV, MDV, non-MDV, and the rumen are given in Tables 5, 6 , 7, and 8, respectively. During the control period, a significant PDV net release of PAA (12 mmol/h) was observed, accounting for 35% of the AA net release (FAA + PAA). This PDV flux of PAA mainly resulted from a MDV release (15 mmol/h) of PAA. For essential PAA, the MDV net flux was 155% (P < .05) of the PDV net flux. Considering individual AA, peptide GlX, Gly, Ala, Val, Ile, Leu, and Pro net fluxes were not significantly different from zero at the PDV level, whereas only GlX and Ala fluxes were not significantly different from zero at the MDV level. Among the PAA, only Gly (P < .10) and Ile (P < .05) showed significant net flux (uptake) across the ruminal wall. During the postinjection period, the variability in total PAA net flux was larger than before injection and a significant increase in total PAA release could not be evidenced. However, the intraruminal injection produced a significant increase in peptide EAA net flux across the MDV (+ 14%; P < .05) and the PDV (+ 140%; P < .10). From the increase in PDV net flux, it can be calculated that, during the postinjection period, 30 mmol of peptide EAA was released in the portal vein in response to the injection. Non-MDV and ruminal net fluxes of peptide EAA were not significantly affected by the injection. Regarding individual AA, the AA solution increased the peptide Ile and AsX net releases across the MDV (P < .05) and the peptide Pro and Phe net releases across the non-MDV (P < .10). A decrease in ruminal tissue net uptake of peptide Ile was observed after the injection (P < .05). At the PDV level, Ile, Leu, and Pro net releases were significantly increased (P < .10).
Discussion
Blood flow measurement is a key point in the determination of nutrient net flux in blood vessels. The technique used in the present experiment to quantify blood flow has been validated previously (Ré mond et al., 1993b (Ré mond et al., , 1998 . The recorded PBF rates are in agreement with the relationship observed in sheep between PBF and ME intake (Ré mond et al., 1998) . Predicted PBF (calculated with the regression obtained from the literature data) was 2,370 mL/min, whereas measured PBF was 2,320 mL/min. The ruminal contribution to PBF observed in the present study (22%) agrees with that observed using the microsphere technique of Barnes et al. (1983) , when data are considered on a daily basis. Because the blood flow probe was implanted on the CMV before the junction with the ileocecocolic vein, the MDV measurements in the present work mainly concerned the small intestine (Neutze et al., 1994) . The MDV blood flow accounted for 21% of the PBF, which is in agreement with the 19% reported by Neutze et al. (1994) using a similar preparation and ultrasonic flow probe. Using the microsphere technique, Barnes et al. (1983) observed a contribution of the small intestine to PBF of approximately 17%, close to that observed with direct measurement in Neutze et al. (1994) and in the present work.
Our preliminary study on peptide determination showed that the estimation of plasma PAA is largely affected by the sample preparation. The chemical deproteinization with SSA is known to leave small quantities of protein in the supernatant (Hubbard et al., 1988; Neutze et al., 1996) , whatever the final concen- Values are means ± SE (n = 4). b EAA = essential amino acids; AsX is Asp for FAA and Asp + Asn for PAA; GlX is Glu for FAA and Glu + Gln for PAA. c P is the probability for postinjection flux to be different from control flux; NS = nonsignificant; **P < .01, *P < .05, †P < .10. tration in SSA. That probably explains the large concentration of AA (7,160 M in the artery) attributed to plasma peptide by McCormick and Webb (1982) . In our study, when the chemical deproteinization was applied without the additional filtration step, approximately 22% of AA attributed to peptides originated in fact from small protein in the supernatant. Therefore, in the studies in which simple deproteinization with SSA was performed (McCormick and Webb, 1982; Danilson et al., 1987; Webb et al., 1992) , peptide net fluxes may have been significantly overestimated. Physical deproteinization of plasma samples present the advantage of a better isolation of the peptide fraction than the chemical method. However, because quick removal of functional protein before sample freezing is necessary to limit the action of plasma peptidases, the ultrafiltration should be performed at the time of sampling. This is not always easy to achieve because of the duration of the filtration. Chemical deproteinization has the advantage that it rapidly removes the protein and keeps samples under acidic conditions, limiting the action of peptidases. However, it must be followed by a filtration step to isolate the peptide fraction properly. For these reasons, the method involving chemical precipitation and ultrafiltration was chosen to determine PAA concentration for flux measurements. 
Values are means ± SE (n = 4).
b EAA = essential amino acids; AsX is Asp for FAA and Asp + Asn for PAA; GlX is Glu for FAA and Glu + Gln for PAA. c P is the probability for postinjection flux to be different from control flux: NS = nonsignificant; **P < .01, *P < .05, †P < .10. In the present work, arterial plasma concentration of low-molecular-weight peptides (< 3 kDa) accounted for 32% of the concentration of the sum of free and peptide AA. This value is close to those previously observed in arterial plasma of ruminants (20 to 28%) with methodologies including a filtration step to separate small peptides (< 1,500 Da) either by HPLC (Seal and Parker, 1996) or by gel filtration (Backwell et al., 1997) .
Nitrogen Net Flux Across the Gastrointestinal Tract
In the present study, because animals were kept in conditions close to steady state (fractional feeding), control fluxes were assumed to be representative of AA net fluxes attributable to the experimental diet.
The contribution of the stomach to portal urea net uptake in steers has been reported to be 33 and 95% with forage and high-concentrate diet, respectively (Huntington, 1989) . In the present study, ruminal and intestinal net uptake of urea accounted for 58 and 16% of the portal net uptake, respectively. Ré mond et al. (2000) observed that in sheep the omasal and abomasal net uptake of urea accounted for only 5% of ruminal net uptake. Thus, it can be estimated that in the present study approximately 23% of the portal net uptake of urea was attributable to pancreatic secretion and urea transfer into the reticulum, duodenum, and large intestine. Endogenous urea entering the intestine via pancreatic secretion is low compared with urea transfer across the gastrointestinal tract wall (Varady et al., 1979) , suggesting that a significant part of portal net uptake could originate from urea net transfer into the large intestine. This observation is in contrast with data obtained with the isotope tracer technique, which showed that the transfer of blood urea across the wall of the large intestine wall of sheep was negligible (Dixon and Nolan, 1983; Dixon and Milligan, 1986) .
The ruminal and MDV net releases of ammonia accounted for 29 and 28% of the portal net release, respectively. Ré mond et al. (2000) showed that ammonia net release in the left gastric vein (draining the omasum, the abomasum, and part of the duodenum) accounted for 36% of ruminal ammonia net release. Applying the same reasoning as used for urea, it seems that the large intestine also plays a significant role in ammonia absorption. Siddons et al. (1985) reported that in forage-fed sheep the large intestine accounted for 16 to 18% of the ammonia absorbed from the digestive tract.
The ratio of PDV:MDV net fluxes of FAA observed during the control period was approximately .70, indi-cating a significant uptake of FAA by the non-MDV tissues. This ratio is in agreement with previous observations in sheep (Neutze et al., 1994; MacRae et al., 1997) and steers (Reynolds and Huntington, 1988; Seal and Parker, 1996) . In the present study, FAA utilization by the rumen accounted for approximately 18% of this non-MDV uptake. A significant uptake of FAA by the omasum and the abomasum (82% of that occurring at the ruminal level) was also reported by Ré -mond et al. (2000) .
In adult sheep fed pelleted lucerne, Backwell et al. (1997) observed that the net flux of low-molecularweight peptide (< 1.5 kDa) across the PDV and the MDV was not significantly different from zero. In the control period of the present study, the PAA net release across the PDV accounted for approximately 35% of the sum of FAA and PAA net release, and it was fully attributable to a MDV net release. In steers, the contribution of low-molecular-weight peptides (< 1.5 kDa) to AA net release across the PDV has been reported to be approximately 65% (Koeln et al., 1993; Seal and Parker, 1996) . In contrast to what was observed in the present study, Seal and Parker (1996) reported a greater PAA net release across the non-MDV than across the MDV. There is currently a lack of data in the literature to understand the origin of the discrepancies Values are means ± SE (n = 4).
b EAA = essential amino acids; AsX is Asp for FAA and Asp + Asn for PAA; GlX is Glu for FAA and Glu + Gln for PAA. c P is the probability for postinjection flux to be different from control flux; NS = nonsignificant; **P < .01, *P < .05, †P < .10. observed between all these studies: ruminant species, nutrition, or physiological state?
The nitrogen digestibility in the total tract was measured in a previous study (Ré mond et al., 1997) and was .67. In the present work, the net disappearance of N in the digestive tract was therefore estimated to be 19.6 g of N/d. The summation of portal FAA, PAA, NH 3 , and urea net fluxes (9.0, 5.5, 13.9, and 7.7 g of N/d, respectively) observed during the control period gave a total PDV net release of 20.7 g of N/d. Salivary and biliary N secretions, on one hand, and absorption of N in forms other than NH 3 , FAA, and PAA, on the other hand, are not taken into account in the portal net balance. Nevertheless, good agreement was observed between digestive and portal balances. These data suggest that PAA fluxes should be taken into account in measurements of AA net flux across the PDV.
Site and Form of Amino Acid Absorption
Casein hydrolysate was used in the injected solution to generate a ruminal pool of nonspecific peptides, as it occurs during the postfeeding period. Furthermore, three dipeptides were added to the casein hydrolysate. The choice of Gly-Gly and carnosine was made simply because they can be measured using a standard AA analysis system. The dipeptide Pro-Phe was added because peptides with Pro at the N-terminus were reported to be more resistant to ruminal degradation than other peptides (Wallace, 1996) and because peptides containing Phe were shown to be utilized for protein synthesis in the mammary gland (Backwell et al., 1996) .
The capacity of the ruminal and the omasal epithelial tissues to absorb peptides has been demonstrated in vitro, using parabiotic chambers (Matthews and Webb, 1995) . One objective of the present study was to determine in vivo the significance of this absorption. Peptides can accumulate in the rumen during the process of feed protein degradation. During the postfeeding period, peptide nitrogen concentrations up to 270 mg/L could be observed in ruminal fluid (Webb and Matthews, 1998) . In the present study, PAA concentration in the rumen, within the 1st h following the injection, was about 500 mg of N/L.
Before injection PAA net flux across the ruminal tissues was not significantly different from zero, and no significant release of PAA was observed after the injection. Furthermore, no absorption of carnosine and Gly-Gly across the rumen wall could be detected. These data contrast with those of a previous study (Ré mond et al., 2000) in which the capacity of the ruminal wall to absorb carnosine was demonstrated in vivo, using a dose infusion of this dipeptide into the rumen. However, in the present experiment lower ruminal concentrations of carnosine were generated by the injection (1.5 vs 4.5 mM). Furthermore, the very low plasma carnosine concentrations observed prevented a precise quantification of carnosine flux, in contrast with previous observations by Ré mond et al. (2000) . Data from these two in vivo studies suggest that peptides can diffuse through the ruminal epithelium but that the actual capacity of this epithelium to absorb peptides is low. Therefore, without a large supply of peptides in the rumen, peptide absorption across the ruminal wall may not contribute significantly to AA release in the PDV.
Significant amounts of injected free and peptide AA escaped ruminal degradation and flowed out of the rumen. Consequently, an increase in PDV net release of FAA was observed after the injection. During the postinjection period, the PDV release of free EAA in response to the injection was 10 mmol, which accounted for only 28% of the ruminal outflow of free and small peptide EAA produced by the injection (36 mmol). When PAA were added to FAA, in response to the injection, the amount of absorbed EAA reached 40 mmol, which is in closer agreement with ruminal escape of injected EAA than when considering FAA alone. The difference could be explained by the contribution of some peptides from casein hydrolysate with a higher molecular weight than 3,000. The increase in peptide EAA net release across the PDV, in response to the injection, was mainly attributable to branchedchain AA that were responsible for 54% of low-molecular-weight peptide AA outflow from the rumen. Similarly, the PDV net release of peptide Pro was significantly increased and that of peptide Phe tended to increase (P = .11), which can be related to the Pro-Phe content of the injected solution. All these observations imply absorption of luminal peptides in the postruminal digestive tract. The apparent discrepancy observed in the present work between nonsignificant absorption of carnosine and Gly-Gly and an increase in peptide net release following the injection might have resulted either from a specificity in absorption processes according to peptide structure or from differences in peptide resistance to epithelial peptidases (Adibi and Kim, 1981) .
Regarding site of AA absorption, the present study showed that 52% of the increase in PDV net release of free EAA originated from the small intestine drained by the MDV preparation. Therefore, the gut section between the rumen and jejunum may contribute significantly to FAA absorption observed in response to the injection of the solution of AA. Ré mond et al. (2000) observed no significant absorption of FAA across the omasum and the abomasum in response to omasal injection of AA. Consequently, the duodenum could be the major site of the FAA absorption observed across the non-MDV in the present study.
Following the injection, a significant increase in peptide EAA net release was observed at the MDV level. This observation argues in favor of a transmucosal passage of luminal peptides in the small intestine. Together with a possible endogenous release of peptides, absorption of luminal peptides could therefore contribute significantly to MDV release of PAA observed during the control period. In nonruminants, the concept of small intestinal absorption of intact peptides is currently well established (Gardner, 1998) . In both ruminant and nonruminant species, the way in which diet affects the extent of this absorption according to the diet requires further investigations.
Non-MDV fluxes were obtained by difference; this generated larger variability than did direct flux measurement, which may have prevented detection of significant effects of injection on total and essential PAA net fluxes. However, considering individual AA, an increase in Pro and Phe peptide net fluxes was observed across the non-MDV tissues, which could be related to Pro-Phe absorption. These data suggest that peptide absorption might occur, not only in the small intestine drained by the MDV preparation (jejunum to distal ileum), but also between the rumen and the jejunum. Omasal wall permeability to dipeptides has been demonstrated in vitro (Matthews and Webb, 1995; MacCollum and Ré mond et al. (2000) have observed carnosine absorption in the left gastric vein (draining omasum and abomasum) in response to omasal injection of carnosine. Furthermore, pepT1 mRNA peptide transporter has been found in sheep omasum (Chen et al., 1999) . In the present work, the experimental approach did not allow us to deter-mine whether the increase in Pro and Phe peptide net release in the non-MDV was attributable to these compartments or to the duodenum.
In conclusion, peptides may contribute significantly to PDV net release of AA in sheep. With the diet used in the present work, this portal release of peptides originated from the intestine and could be at least partly attributable to peptide absorption from the intestinal lumen. The rumen does not seem to be a major site of peptide absorption. In sheep, apart from particular feeding situations generating high concentrations of peptides in the rumen, the absorption of peptides from the gut section between the rumen and the distal duodenum seemed low. However, the ruminant species and the physiological state of the animal could play a significant role in determining the extent of this absorption. Above all, collection of more data is necessary to clearly determine the significance of the small peptide pool in the rumen and its variations according to the diet.
Implications
The results presented here confirmed that low-molecular-weight peptides might contribute significantly to amino acid net release in the portal vein of ruminants. Evidence for absorption of intact peptides across the gastrointestinal tract of ruminants is accumulating. Nevertheless, both the extent and the site of this absorption still remain unclear. Further direct measurements of peptide fluxes across the different segments of the gut are required to elucidate the differences observed between ruminant species and to determine the impact of the diet on these fluxes.
